Glioma susceptibility 9

Preferred Label : Glioma susceptibility 9;

Obsolete resource : true;

Moved to : 615848;

Symbol : GLM9;

CISMeF acronym : GLM9;

Type : Phenotype, molecular basis known;

Inheritance : Autosomal dominant;

Molecular basis : Susceptibility conferred by mutation in the protection of telomeres 1 gene (POT1, 606478.0009);

Neoplasia : Astrocytoma, increased risk of; Oligodendrogliomas, increased risk of; Glioma, increased risk of; Increased risk of other cancers (e.g., kidney cancer, lung cancer, and leukemia);

Prefixed ID : 616568;

Details

Origin ID

616568;

UMLS CUI

C4225278;

Automatic exact mappings (from CISMeF team)
- POT1 wt Allele [NCIt concept]
HPO term(s)
- Adult onset [HPO term]
- Astrocytoma [HPO term]
- Autosomal dominant inheritance [HPO term]
- Glioma [HPO term]
- Incomplete penetrance [HPO term]
- Leukemia [HPO term]
ORDO concept(s)
- Anaplastic oligodendroglioma [ORDO Disease]
- Oligodendroglioma [ORDO Disease]
Semantic type(s)
- Finding [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients